How would you like your name to appear on your certificate?

Profession

What activities did you attend at the event?

Friday, November 15 - 1:10 - 1:30 - J Roberts, MD

Friday, November 15 - 1:30 - 1:50 - A Posselt, MD, PhD

Friday, November 15 - 1:50 - 2:10 - D Brandman, MD, MAS

Friday, November 15 - 2:10 - 2:40 - M Peters, MD

Friday, November 15 - 3:10 - 3:40 - N Mehta, MD and R Hirose, MD

Friday, November 15 - 3:40 - 4:00 - Peter Stock, MD, PhD

Friday, November 15 - 4:00 - 4:30 - Norah Terrault, MD, MPH

Friday, November 15 - 4:30 - 4:50 - Philip Rosenthal, MD

Friday, November 15 - 4:50 - 5:20 - Q & A

Saturday, November 15 - 9:00 - 9:40 / 9:00 - 10:00 - Concurrent Sessions

Saturday, November 16 - 9:40 - 10:20 / 10:00 - 11:00 - Concurrent Sessions

Saturday, November 16 - 10:30 - 11:15 / 11:00 - 12:00 - Concurrent Sessions

Saturday, November 16 - 11:15 - 12:00 - Pediatric Sessions

Saturday, November 16 - 12:00 - 12:30 - Q & A

Agreement

By completing this form, you attest that you have participated in all selected activities in thier entirety.

I agree

Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.

Please rate the following:

The program was relevant to my work.

Content matched stated objectives.

Usefulness of handouts/AV.

Quality of facilities.

How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?

If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain in detail (e.g. session title, speaker name, situtation):

If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:

How well are you able to meet the session objectives?

Having completed the activity, please rate your ability to meet each of the following objectives:

Identify the risks to the donor for living liver donation

List the benefit to the recipient for living donor liver transplant

Discuss the indications for total pancreatectomy and autoislet transplantation

Describe general outcomes of the procedure as regards improvement in pain, insulin independence, and overall quality of life

Describe patient factors/characteristics that are associated with higher insulin independence rates

Describe what constitutes a "healthy diet" for patients with end stage liver disease

Discuss the fitness level of patients with end stage liver disease

Diagnose various forms of autoimmune liver disease

Diagnose and manage cross over syndromes of autoimmune liver diseases

Discuss changes in MELD exception policies since 2002 as they relate to both stage T1 and T2 hepatocellular carcinoma

Address the outcomes of "watchful watching" in a large cohort of stage T1 HCC patients while awaiting progression to stage T2 when they then can be listed with MELD exception

Discuss the overall safety and efficacy of liver transplantation in the HIV infected recipient

List strategies to improve outcomes following liver transplantation in the HIV/HCV coinfected recipient

Discuss new HCV drug classes and how they may be used in transplant candidates and recipients

Review treatment strategies for prevention of HCV recurrence, including all oral regimens

Cite current theories on NAFLD pathogenesis

Identify current guidelines for NASH diagnosis in children and adolescents

Discuss the evidence-based recommendations for pediatric NAFLD treatment

Discuss the epidemiology of presentation of HSV hepatitis

Determine when empiric treatment is warranted

Discuss issues involved in the complex decision to list a patient with acute liver failure for liver transplantation

Discuss anatomic issues in liver transplantation

Cite the difference between a "piggyback" liver transplant versus a "bicaval" liver transplant

Discuss the natural history of HBV (hepatitis B) in children

Discuss screening recommendations and current treatment options for children with HBV (hepatitis B)

Recognize complications associated with cirrhosis in pediatric patients

Recognize transplant and immunosuppression related complications after pediatric liver transplant

Discuss strategies for, and risks and benefits of, immunosuppression minimization

Review indications for combined liver/kidney transplant

Review the pre-transplant evaluation and the UNOS waitlist process

Identify options for therapy of autoimmune hepatitis

Detail pros and cons of current and near-future post-transplant HCV therapies

Discuss the current approved treatment options for HCV (hepatitis C) in children

Review the latest literature on outcomes related to HSV hepatitis

Discuss the unique candidacy differences for treatment of HCV (hepatitis C) in children

Discuss diagnostic approaches and treatment options for complications associated with cirrhosis in pediatric patients

Objective 1: Identify disease specific issues in liver transplantation

By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.

By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.

By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.

Objective 2: Discuss new and evolving treatments for viral hepatitis

By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.

By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.

By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.

Objective 3: Discuss controversial and complex management issues in liver transplantation including HCC, HIV and nutrition

By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.

By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.

By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.

Objective 4: Assess for the management pre- and post-operative complications associated with pediatric liver transplantation

By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.

By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.

By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.

Please answer the following:

Do you believe this activity was appropriate for the scope of your professional activities?

Was the educational content scientifically sound?

If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?

Was the mode of education effective to learning?

If you answered "No" to any of the above questions, please explain.

Did you perceive any product/service/company/commercial bias in any educational session you attended or materials you received?

If you answered "Yes" to the above question, please detail the situation below (e.g. session title, speaker name):

Were you solicited by sales personnel in an educational room (other areas do not matter) while you attended this educational activity?

If you answered "Yes" to the above question, please explain in detail (e.g. who, when, where):

How much did you learn as a result of this education program?

What specifically did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient/client problems or patient/client challenges do you feel you are not able to address appropriately or to your satisfaction?

What problems are your patients/clients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

Basic

Intermediate

Advanced

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?

Additional comments: